Nexthera Capital

Nexthera Capital operates as an investment manager, employing a fundamental long/short equity strategy focused on the global healthcare sector. The firm specializes in therapeutics, targeting publicly listed pharmaceutical and biotechnology companies. It leverages deep expertise in scientific data, technology, and regulation to achieve capital appreciation and alpha generation.

Daniel Malek founded Nexthera Capital in 2015, driven by insight that healthcare’s complex scientific advancements and regulatory shifts create unique investment opportunities. Malek, with his equity research background, established the firm to apply specialized domain knowledge. His vision was to navigate the sector’s high barriers to entry for investors.

The firm provides investment management services to institutional and qualified private clients. Nexthera Capital’s vision is to consistently generate superior returns by strategically investing in impactful medical innovations. It capitalizes on the dynamic drug development cycle that significantly advances patient well-being.